CCR5 and ischemic stroke: However, the role of CCR5 to improve outcome after ischaemic stroke in humans is unknown.<h4>Methods and analysis</h4>MAraviroc for STrokE Recovery is a phase II, single-centre, randomised, double-blind, placebo-controlled trial.